| 時間 | 201A | 201BC | 201DE | 201F |
|---|---|---|---|---|
| 09:00 10:20 | 介入2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for Acute Pulmonary Embolism: 5 Categories (A–E) | 心衰Reversing Cardiac Remodeling in Heart Failure: From Bench to Bedside and Beyond | 跨領域Cross Discipline Symposium | 急重症Joint Committee of Critical Care Medicine Certified CourseRegistration Only・09:00–12:05 |
| 10:20 10:40 | Healthy Break | |||
| 10:40 12:00 | 介入Mastering Complex Coronary Interventions: Navigating TAVI-PCI and Left Main Challenges | 心衰Unlocking New Horizons in Heart Failure: The Cardiorenal Synergy of nsMRA | 跨世紀基金會TSOC-NCHCPF* Joint Session | |
| 12:10 13:30 | Luncheon Symposium[Novo Nordisk] | Luncheon Symposium[Alnylam] | Luncheon Symposium[Sanofi] | Luncheon Symposium[Boehringer Ingelheim] |
Opening Remarks
林姝含 (Donna Shu-Han Lin)林姝含 (Donna Shu-Han Lin)
Life After p < 0.05: The Statistical Errors Reviewers Catch Most
林星帆 (Alfred Hsing-Fen Lin)Q & A
連朕緯 (Cheng-Wei Lien)
My AI Research Assistants: Honest Lessons from Daily Practice
許容綺 (Jung-Chi Hsu)Q & A
張喬翔 (Chiao-Hsiang Chang)
AI Has Entered the Ward. Now What? The Last Mile from Model to Patient
林嶔 (Chin Lin)Q & A
Closing Remarks
張喬翔 (Chiao-Hsiang Chang)Opening Remarks & Introduction
林彥宏 (Yen-Hung Lin)林彥宏 (Yen-Hung Lin)
Treatment of Resistant Hypertension in The ERA of Aldosterone
Sungha Park (Korea)Q & A
鄭浩民 (Hao-Min Cheng)
Primary Aldosteronism: The Current Status and Future Perspectives
Mitsuhide Naruse (Japan)Q & A
吳志成 (Chih-Cheng Wu)、葉志凡 (Chih-Fan Yeh)
PRO
陳政瑋 (Zheng-Wei Chen)CON
蕭健皓 (Chien-Hao Hsiao)Discussion
Closing Remarks
陳郁志 (Michael Yu-Chih Chen)Opening Remarks
王俊力 (Chun-Li Wang)李廣祚 (Kuang-Tso Lee)
Case Presentation
李禎元 (Jen-Yuan Lee)Q & A
AllRecap
唐嘉駿 (Chia-Chun Tang)郭泠 (Ling Kuo)
Case Presentation
李慶威 (Ching-Wei Lee)Q & A
AllRecap
秦志輝 (Chih-Hui Chin)Closing Remarks
秦志輝 (Chih-Hui Chin)Cardiac MR Assessment in Repaired TOF: From RV and Pulmonary Regurgitation Quantification to PPVI Decision-Making
Opening Remarks
林銘泰 (Ming-Tai Lin)曾偉杰 (Wei-Chieh Tseng)
The National Taiwan University Children's Hospital Experience
黃柔瑄 (Jou-Hsuan Huang)鍾宏濤 (Hung-Tao Chung)
The Linkou Chang Gung Memorial Hospital Experience
張志丞 (Chih-Chen Chang)詹聖霖 (Sheng-Ling Jan)
The Taichung Veterans General Hospital Experience
鄭允中 (Yun-Chung Cheng)王玠能 (Jieh-Neng Wang)
The National Cheng Kung University Hospital Experience
黃莉婷 (Li-Ting Huang)鄭敬楓 (Ching-Feng Cheng)
Panel Discussion
Closing Remarks
葉樹人 (Shu-Jen Yeh)Opening Remarks
羅皓允 (Hao-Yun Lo)羅皓允 (Hao-Yun Lo)
Stay, Leave, Return: One Cardiologist's Career Journey
洪惠風 (Huei-Fong Hung)Q & A
宋偉廷 (Wei-Ting Sung)
First Flight: A Practical Guide to Your First NSTC Grant
徐千彝 (Chien-Yi Hsu)Q & A
吳立智 (Li-Chih Wu)
Before You Pack: The Realities and Romance of Training Abroad
蔡承烜 (Cheng-Hsuan Tsai)Q & A
Closing Remarks
吳立智 (Li-Chih Wu)Opening Remarks
謝宜璋 (I-Chang Hsieh)吳懿哲 (Yih-Jer Wu)
What's New about Taiwan and Global PH Guideline?
吳書豪 (Shu-Hao Wu)賀萬靖 (Wan-Jing Ho)
What's New about PAH Target Therapy? From Global Trial to Real World Experience
吳俊賢 (Chun-Hsien Wu)邱昱偉 (Yu-Wei Chiu)
What's New about Non-PAH PH? Challenges and Opportunities for Group 2 & Group 3 PH
林佳淩 (Jia-Ling Lin)劉維新 (Wei-Shin Liu)
Panel Discussion
AllClosing Remarks
許志新 (Chih-Hsin Hsu)Opening Remarks
洪明銳 (Ming-Jui Hung)劉文浩 (Wen-Hao Liu)
Breathless and Pregnant: When to Image, When to Wait
王英謙 (Ying-Chien Wang)Q & A
林芬瓊 (Fen-Chiung Lin)
Clean Coronaries, Unresolved Pain: Rethinking Chest Pain After Menopause
湯文德 (Wen-De Tang)Q & A
林維文 (Wei-Wen Lin)
Radiation-induced Cardiovascular Risk in Breast Cancer: What can Image Reveal
賴姿妤 (Tzu-Yu Lai)Q & A
楊甯貽 (Ning-I Yang)
When Her Heart Speaks the Language of Autoimmunity
宋國慈 (Kuo-Tzu Sung)Q & A
Closing Remarks
蔡惟全 (Wei-Chuan Tsai)Ped CVS Educational Session: VSD
Surgical Approach for VSD Type I and II
Opening Remarks
林銘泰 (Ming-Tai Lin)李必昌 (Pi-Chang Lee)
Preoperative Evaluation: Images and Hemodynamics
林竹川 (Chu-Chuan Lin)黃書健 (Shu-Chien Huang)
Establishing Extracorporeal Circulation and Myocardial Protection
周恒文 (Heng-Wen Chou)林宜君 (I-Chun Lin)
Tips in Type I VSD Repair
潘俊彥 (Jun-Yen Pan)張重義 (Chung-I Chang)
Tips in Type II VSD Repair
徐綱宏 (Kang-Hong Hsu)游昌憲 (Chang-Hsien Yu)
Panel Discussion
Closing Remarks
張仁平 (Jen-Ping Chang)Sponsored by AstraZeneca
Opening Remarks
謝宜璋 (I-Chang Hsieh)謝宜璋 (I-Chang Hsieh)
Rethinking Uncontrolled Hypertension: Insights from the 2026 uHTN Consensus
王宗道 (Tzung-Dau Wang)許志新 (Chih-Hsin Hsu)
Optimizing Cardiorenal Care with Novel Strategies for Hyperkalemia Management
張嘉修 (Chia-Hsiu Chang)Panel Discussion
Closing Remarks
許志新 (Chih-Hsin Hsu)Sponsored by Daiichi Sankyo
Opening Remarks
吳懿哲 (Yih-Jer Wu)吳懿哲 (Yih-Jer Wu)
Global Outcomes & Long-Term Precision in Japan
Shizuya Yamashita (Japan)CLEAR TW Overview
吳彥雯 (Yen-Wen Wu)Panel Discussion
Closing Remarks
吳懿哲 (Yih-Jer Wu)Sponsored by Boehringer Ingelheim
Opening Remarks
王俊傑 (Chun-Chieh Wang)王俊傑 (Chun-Chieh Wang)
Strategic Management in HF: Identifying Treatment Gaps and Optimizing the Care Journey
宋思賢 (Shih-Hsien Sung)黃金隆 (Jin-Long Huang)
Case Sharing: Translating HF Strategy into Practice—From Treatment Decisions to Follow-up
王宇澄 (Yu-Chen Wang)Panel Discussion
Closing Remarks
黃金隆 (Jin-Long Huang)Sponsored by Novartis
高憲立 (Hsien-Li Kao)
The Next Chapter of siRNA-Based LDL-C Management – Lessons Learned and Evidence Awaited
林肇鋒 (Chao-Feng Lin)葉宏一 (Hung-I Yeh)
Beyond RAAS Blockade: The Science of Neprilysin Inhibition for Hypertension Management
林柏霖 (Po-Lin Lin)Opening Remarks
謝敏雄 (Ming-Hsiung Hsieh)陳永隆 (Yung-Lung Chen)
PFA for AF: What Have We Learned From Recent Clinical Trials?
李威杰 (Wei-Chieh Lee)林亮宇 (Lian-Yu Lin)
PFA in Persistent AF: Beyond Pulmonary Vein Isolation
鐘法博 (Fa-Po Chung)葉勇信 (Yung-Hsin Yeh)
Next-Generation PFA in Complex AF Ablation: Redo Procedures and Non-PV Targets
廖英傑 (Ying-Chieh Liao)羅力瑋 (Li-Wei Lo)
PFA Safety: Coronary Spasm, Cerebral Events, and Emerging Complications
李冠毅 (Guan-Yi Li)Panel Discussion
Closing Remarks
蔡青峰 (Chin-Feng Tsai)Opening Remarks
王宗道 (Tzung-Dau Wang)賴超倫 (Chao-Lun Lai)
Defining Uncontrolled Hypertension: A-anchored Single-Pill Combination as the Foundation and Phenotype-Guided Care
鄭浩民 (Hao-Min Cheng)方燕楠 (Yen-Nan Fang)
SMARTER-S: Sympathetic Overactivity, Morning Hypertension, and Obstructive Sleep Apnea
葉日凱 (Jih-Kai Yeh)翁國昌 (Kwo-Chang Ueng)
SMARTER-M: Metabolic Syndrome and Obesity
林柏霖 (Po-Lin Lin)王岡陵 (Kang-Ling Wang)
SMARTER-A: Targeting Aldosterone Excess and Low-Renin Hypertension
蔡承烜 (Cheng-Hsuan Tsai)詹益欣 (Yi-Hsin Chan)
SMARTER-R: Renal Decline and Chronic Kidney Disease
林姝含 (Donna Shu-Han Lin)洪明銳 (Ming-Jui Hung)
Panel Discussion
Closing Remarks
趙庭興 (Ting-Hsing Chao)Aortic Valve
Opening Remarks
殷偉賢 (Wei-Hsian Yin)殷偉賢 (Wei-Hsian Yin)
Aortic Stenosis and Coronary Artery Disease: Which Should Be Treated First?
陳盈憲 (Ying-Hsien Chen)王朝永 (Chao-Yung Wang)
Select TAVR, but Think PCI: How to Guarantee Easy Coronary Re-access after TAVR
陳東藝 (Dong-Yi Chen)鄭正忠 (Cheng-Chung Cheng)
Management of Acute Coronary Complications during TAVR
林煥湫 (Huan-Chiu Lin)施志遠 (Jhih-Yuan Shih)
Post TAVR PCI: Tips and Tricks
蕭富致 (Fu-Chih Hsiao)方修御 (Hsiu-Yu Fang)
Panel Discussion
Closing Remarks
黃啟宏 (Chi-Hung Huang)Precision Repair, Transcatheter Intervention, Minimally Invasive Surgery, and Heart Team Decision-Making
Opening Remarks
陳益祥 (Yih-Sharng Chen)蔡建松 (Chien-Sung Tsai)
Pulmonary Root Translocation in the Repair of CCTGA Compared to the Rastelli Procedure
Jose Da Silva (USA)諶大中 (Ta-Chung Shen)
Standardizing Robotic Mitral Valve Surgery: Technique, Reproducibility, and Team Workflow
紀乃新 (Nai-Hsin Chi)阮俊能 (Jun-Neng Roan)
Complex Mitral Valve Surgery: Redo Procedures, Barlow Disease, and Mitral Annular Calcification
蔡宜廷 (Yi-Ting Tsai)張忠毅 (Chung-Yi Chang)
Transcatheter Mitral Valve Repair: Patient Selection, Timing, and the Role of the Heart Team
李永在 (Yung-Tsai Lee)Panel Discussion: Choosing Between Transcatheter and Surgical Strategies for Mitral and Tricuspid Valve Disease
Closing Remarks
葉集孝 (Chi-Hsiao Yeh)Opening Remarks
柯文欽 (Wen-Chin Ko)葉勇信 (Yung-Hsin Yeh)
The Evolving ICD Landscape: Subcutaneous and Extravascular ICDs
簡育珊 (Yu-Shan Chien)郭任遠 (Jen-Yuan Kuo)
Leadless Pacing: From Single-Chamber to Dual-Chamber Therapy
卓士傑 (Shih-Jie Jhuo)張伯丞 (Po-Cheng Chang)
Conduction System Pacing: Is It Becoming the New Standard?
黃嵩豪 (Sung-Hao Huang)葉冠宏 (Kuan-Hung Yeh)
Lead Extraction in 2026: Safer Tools, Better Strategies, Tougher Decisions
吳宏彬 (Hung-Pin Wu)林晏年 (Yen-Nien Lin)
CIED Infection: Prevention, Diagnosis, and the Leadless Solution
蔡適吉 (Su-Kiat Chua)Panel Discussion
Closing Remarks
謝育整 (Yu-Cheng Hsieh)Opening Remarks
葉宏一 (Hung-I Yeh)林彥璋 (Yenn-Jiang Lin)
Engineering Biological Pacemakers: Translating Cardiac Reprogramming into Regenerative Therapy
劉至民 (Chih-Min Liu)吳彥雯 (Yen-Wen Wu)
Targeting Cardiac Fibroblast Plasticity for Myocardial Repair and Heart Failure
楊鎧鍵 (Kai-Chien Yang)柯文欽 (Wen-Chin Ko)
Genetic Determinants of Coronary Artery Disease and Its Risk Factors: GWAS, Mendelian Randomization, and Polygenic Risk Scores for Precision Medicine
柯毓麟 (Yu-Lin Ko)陳肇文 (Jaw-Wen Chen)
Precision Therapeutics in Cardiometabolic Disease: Translating Mechanisms into Targeted Cardiovascular Care
蔡維中 (Wei-Chung Tsai)劉邦彥 (Pang-Yen Liu)
Precision Cardio-Oncology in the Immuno-Oncology Era: Insights from the Taiwan Immuno-Oncology Cardiovascular Risk Registry
蘇俐瑋 (Li-Wei Su)Closing Remarks
吳造中 (Chau-Chung Wu)Trans-catheter Mitral Valve Intervention: From Basic to Advanced
Opening Remarks
許榮城 (Jung-Cheng Hsu)林茂欣 (Mao-Shin Lin)
M-TEER in Secondary Mitral Regurgitation: Who, When, and How Early?
謝慕揚 (Mu-Yang Hsieh)李慶威 (Ching-Wei Lee)
Complex M-TEER: Achieving Optimal MR Reduction Without Creating Mitral Stenosis
張俊欽 (Chun-Chin Chang)謝宜璋 (I-Chang Hsieh)
Failed Surgical Mitral Valves: Valve-in-Valve or Valve-in-Ring—Same Device, Different Challenges
王朝永 (Chao-Yung Wang)殷偉賢 (Wei-Hsian Yin)
Preventing neo-LVOT Obstruction: CT Prediction, LAMPOON or Septal Reduction?
李永在 (Yung-Tsai Lee)宋思賢 (Shih-Hsien Sung)
Panel Discussion
Closing Remarks
謝宜璋 (I-Chang Hsieh)Opening Remarks
黃柏勳 (Po-Hsun Huang)黃柏勳 (Po-Hsun Huang)
Lipid Management in 2026: Are We Treating LDL-C Early and Intensively Enough?
張俊欽 (Chun-Chin Chang)劉秉彥 (Ping-Yen Liu)
Lp(a): The Emerging Risk Factor Is In the Spotlight
黃逸羣 (Yi-Chun Huang)吳志成 (Chih-Cheng Wu)
High Lp(a) in Clinical Practice: What Should We Do Today?
陳東藝 (Dong-Yi Chen)王朝永 (Chao-Yung Wang)
Beyond LDL-C: The Future of Lp(a)-Lowering Therapy
吳卓鍇 (Cho-Kai Wu)許栢超 (Po-Chao Hsu)
Panel Discussion: The Unresolved Questions in Lipid Management
AllClosing Remarks
許栢超 (Po-Chao Hsu)超越心血管保護:守護腦部健康與預防中風
Sponsored by Synmosa
Opening Remarks
林彥宏 (Yen-Hung Lin)林彥宏 (Yen-Hung Lin)
Hypertension Recent Advances and Preventive Strategies in Hypertension and Cognitive Impairment
洪崇烈 (Chung-Lieh Hung)王俊傑 (Chun-Chieh Wang)
2026 APHRS AF Guidelines: Key Messages and What’s New
趙子凡 (Tze-Fan Chao)Panel Discussion
Closing Remarks
王俊傑 (Chun-Chieh Wang)Sponsored by BMS
Opening Remarks
陳文鍾 (Wen-Jone Chen)陳文鍾 (Wen-Jone Chen)
Transforming Obstructive HCM Care: From Evidence to Clinical Practice
Weiqin Lin (Singapore)Panel Discussion
Closing Remarks
陳文鍾 (Wen-Jone Chen)Sponsored by GSK
Opening Remarks
殷偉賢 (Wei-Hsian Yin)殷偉賢 (Wei-Hsian Yin)
RSV-Related Cardiovascular Outcomes: Real-World Evidence from CLEAR-VE
邱昱棋 (Yu-Chi Chiu)趙庭興 (Ting-Hsing Chao)
From Bidirectional Association to Practice: Integrating Shingles Prevention into Cardiovascular Care
陳則瑋 (Tse-Wei Chen)Panel Discussion
Closing Remarks
趙庭興 (Ting-Hsing Chao)Sponsored by MSD
Opening Remarks
吳懿哲 (Yih-Jer Wu)吳懿哲 (Yih-Jer Wu)
LDL-C to Goal Matters: Rethinking LDL-C Management in ASCVD Prevention
吳彥雯 (Yen-Wen Wu)Evolving PAH Management: Integrating New Evidence into Clinical Practice
宋思賢 (Shih-Hsien Sung)Panel Discussion
Closing Remarks
吳懿哲 (Yih-Jer Wu)Opening Remarks
曹殿萍 (Tien-Ping Tsao)陳俊吉 (Chun-Chi Chen)
Acute PE Diagnosis and Risk Stratification (A–E)
黃民評 (Min-Ping Huang)Q & A
許栢超 (Po-Chao Hsu)
Interventional Advanced Management of PE and the Role of IVC Filter
張嘉修 (Chia-Hsiu Chang)Q & A
李政翰 (Cheng-Han Lee)
Acute Management of PE: Medical Treatment and Hemodynamic Support
鍾文榮 (Wen-Jung Chung)Q & A
吳承學 (Cheng-Hsueh Wu)
Follow-Up Care for Acute PE and CTEPD/CTEPH
朱俊源 (Chun-Yuan Chu)Q & A
Closing Remarks
蔡政廷 (Cheng-Ting Tsai)Opening Remarks
謝宜璋 (I-Chang Hsieh)王兆弘 (Chao-Hung Wang)
Precision Diagnostics in Cardiac Remodeling: Novel Biomarkers and Clinical Mapping
吳卓鍇 (Cho-Kai Wu)林文雄 (Wen-Hsiung Lin)
Rethinking GDMT: Omics-Driven Phenotyping and Molecular Mechanisms of Reverse Remodeling
謝明哲 (Ming-Jer Hsieh)莊志明 (Jimmy Jyh-Ming Juang)
Next-Gen Therapeutics: Gene Editing and Regenerative Medicine in HF
謝清河 (Patrick Ching-Ho Hsieh)蔡建松 (Chien-Sung Tsai)
Unloading the Failing Heart: MCS as a Catalyst for Reverse Remodeling and Myocardial Recovery
楊翔宇 (Hsiang-Yu Yang)張懷仁 (Huai-Ren Chang)
Exercise as Medicine: Pushing the Physiological Boundaries of Reverse Cardiac Remodeling
曾炳憲 (Bing-Hsiean Tzeng)洪崇烈 (Chung-Lieh Hung)
Panel Discussion
AllClosing Remarks
洪崇烈 (Chung-Lieh Hung)Opening Remarks
吳彥雯 (Yen-Wen Wu)吳彥雯 (Yen-Wen Wu)
AI-Guided Atrial Fibrillation Ablation: Predicting Success and Personalizing Treatment
林彥璋 (Yenn-Jiang Lin)王俊力 (Chun-Li Wang)
AI-Powered Echocardiography: From Automated Strain Assessment to Clinical Implementation
黃冠智 (Kuan-Chih Huang)Panel Discussion & Closing Remarks
林錦生 (Chin-Sheng Lin)Opening Remarks
詹世鴻 (Shih-Hung Chan)陳恬恩 (Tien-En Chen)
Cardiovascular Health in Menopausal Women: From a Gynecologist's Perspective
賴宗炫 (Tsung-Hsuan Lai)張嘉修 (Chia-Hsiu Chang)
Facing Menopausal Women: What Should Cardiologists Know?
陳美綾 (Mei-Ling Chen)Panel Discussion
Closing Remarks
吳彥雯 (Yen-Wen Wu)Critical Care in Transition: New Frontiers and Emerging Challenges
Opening Remarks
黃群耀 (Chun-Yao Huang)蔡宗能 (Tsung-Neng Tsai)
Navigating the Digital Frontier in Critical Care: Real-World Lessons in AI Development and Implementation
張喬翔 (Chiao-Hsiang Chang)藍偉仁 (Weiren Lan)
Management of Acutely Decompensated Pulmonary Hypertension
鍾昇穎 (Sheng-Ying Chung)吳懿哲 (Yih-Jer Wu)
Panel Discussion
Closing Remarks
許志新 (Chih-Hsin Hsu)Healthy Break
Opening Remarks
謝宜璋 (I-Chang Hsieh)吳書豪 (Shu-Hao Wu)
Bedside Hemodynamic Management of Acute Right Ventricular Failure
林佳淩 (Jia-Ling Lin)葉日凱 (Jih-Kai Yeh)
Advanced Therapies for RV Failure and High-Risk Pulmonary Embolism: Catheter Intervention and Mechanical Support
張捷宇 (Chieh-Yu Chang)黃昱彰 (Yu-Chang Huang)
Panel Discussion
Closing Remarks
王晨旭 (Chen-Hsu Wang)Opening Remarks
曹殿萍 (Tien-Ping Tsao)殷偉賢 (Wei-Hsian Yin)
Timing and Strategy: When and How to Revascularize in the Era of TAVI
王子林 (Tzu-Lin Wang)王怡智 (Yi-Chih Wang)
Anatomical Hurdles: Overcoming Coronary Access Challenges Post-TAVI
劉怡凡 (I-Fan Liu)吳道正 (Tao-Cheng Wu)
Left Main Revascularization: Current Guidelines and Imaging-Guided Optimization
周琰璉 (Yen-Lien Chou)郭風裕 (Feng-Yu Kuo)
Bifurcation Mastery: Technical Pearls and Pitfalls in Complex Left Main PCI
李信賦 (Hsin-Fu Lee)Panel Discussion
Closing Remarks
蔡政廷 (Cheng-Ting Tsai)Opening Remarks
洪明銳 (Ming-Jui Hung)陳文鍾 (Wen-Jone Chen)
Dual Pathway Synergy: Combining nsMRA with SGLT2i in Cardiorenal Continuum
徐千彝 (Chien-Yi Hsu)潘國利 (Kuo-Li Pan)
Navigating HF Phenotypes: nsMRA across HFpEF, HFrEF, HFmrEF, and HFimpEF
許育誠 (Yu-Cheng Hsu)張鴻猷 (Hung-Yu Chang)
Biomarker-Guided Cardiorenal Therapy: Timing the Optimal Initiation of nsMRA
陳柏升 (Po-Sheng Chen)吳彥雯 (Yen-Wen Wu)
Translating Evidence to Practice of nsMRA Clinical Indication, Titration, Safety Monitoring, and Hyperkalemia Management
蔡宗能 (Tsung-Neng Tsai)林宗憲 (Tsung-Hsien Lin)
Ongoing Clinical Trials in nsMRA
王俊力 (Chun-Li Wang)洪崇烈 (Chung-Lieh Hung)
Panel Discussion
AllClosing Remarks
洪崇烈 (Chung-Lieh Hung)Opening Remarks
黃瑞仁 (Juey-Jen Hwang)張重義 (Chung-I Chang)
The Cone Repair for Ebstein's Anomaly: Surgical Variations and Results
Jose Da Silva (USA)莊志明 (Jimmy Jyh-Ming Juang)
How Best to Treat TBADs Extending into the Arch, Its Branches or Ascending Aorta: When Open, When Endo, When Hybrid
吳毅暉 (I-Hui Wu)Closing Remarks
謝宜璋 (I-Chang Hsieh)Sponsored by Novo Nordisk
Opening Remarks
謝宜璋 (I-Chang Hsieh)謝宜璋 (I-Chang Hsieh)
The Prevention, Evaluation, and Management of CKLM Syndrome
陳健弘 (Chien-Hung Chen)A Change of Heart: Rethinking Cardiovascular Care with GLP-1RA
林宗憲 (Tsung-Hsien Lin)Panel Discussion
Closing Remarks
謝宜璋 (I-Chang Hsieh)Sponsored by Alnylam
Opening Remarks
王俊力 (Chun-Li Wang)王俊力 (Chun-Li Wang)
Improving the Recognition and Management of ATTR-CM: From Red Flags to Current Treatment Landscape
賴志泓 (Chih-Hung Lai)Panel Discussion
Closing Remarks
王俊力 (Chun-Li Wang)Sponsored by Sanofi
Opening Remarks
洪明銳 (Ming-Jui Hung)洪明銳 (Ming-Jui Hung)
From Pixels to Precision: Applying AI Across Cardiovascular Imaging Modalities to Detect, Stratify and Monitor Cardiomyopathy
洪崇烈 (Chung-Lieh Hung)黃群耀 (Chun-Yao Huang)
Real-World Practice in Fabry Disease and HCM: Practical Steps for Ongoing Clinical Management in TVGH
郭泠 (Ling Kuo)Panel Discussion
Closing Remarks
黃群耀 (Chun-Yao Huang)Sponsored by Boehringer Ingelheim
Opening Remarks
陳文鍾 (Wen-Jone Chen)陳文鍾 (Wen-Jone Chen)
HF PRIME Protocol: Building a Standardized Pathway for Optimal HF Care
吳彥雯 (Yen-Wen Wu)HF PRIME Practice: Translating the Protocol into Real-World Care
曾炳憲 (Bing-Hsiean Tzeng)Panel Discussion
Closing Remarks
陳文鍾 (Wen-Jone Chen)